Effects of interferons on proliferation and collagen synthesis of rat palatal wound fibroblasts

https://doi.org/10.1016/S0003-9969(99)00037-0Get rights and content

Abstract

The purpose was to select drugs that specifically reduce collagen synthesis by palatal granulation fibroblasts without affecting their proliferation. Granulation fibroblasts were obtained from 8-day-old palatal mucoperiosteal wounds and normal fibroblasts from palatal tissue of unwounded rats. Cultured cells were treated with interferon-α2b, interferon-β and interferon-γ (0, 100, 1000, and 10000 U/ml). Cell proliferation was measured by [3H]thymidine incorporation. Collagen synthesis and non-collagenous protein synthesis were determined from the incorporation of [3H]proline. None of the interferons significantly inhibited the proliferation of either type of fibroblasts. Interferon-α2b had no effect on the variables studied at the dosages used. Interferon-β reduced collagen synthesis of granulation fibroblasts without affecting their non-collagenous protein synthesis or protein synthesis by normal fibroblasts. Interferon-γ reduced collagen synthesis of both types of fibroblast and the non-collagenous protein synthesis of granulation fibroblasts. These data show that interferon-β specifically reduces collagen synthesis by oral granulation fibroblasts without affecting normal palatal fibroblasts.

Introduction

Scar formation after cleft palate surgery is one of the major factors causing aberrant maxillary growth and dento-alveolar development (Ross, 1987). Consequently, the inhibition of scar formation seems a feasible way of improving the clinical outcome.

Tissue injury triggers a complex cascade of cellular and biochemical events that finally results in a scar. After injury, there is inflammation, fibroblast proliferation, matrix synthesis and remodelling (Witte and Barbul, 1997). Every phase contributes to the amount of scarring by influencing the rate, quality and total amount of matrix deposition. Oral palatal wounds also pass through these phases of wound healing (Kahnberg and Thilander, 1982). The number of collagen fibres in palatal mucoperiosteal wounds is increased up to 4 weeks after wounding (Searls et al., 1979). This seems to be due not only to an increased number of cells but also to an increase in collagen production per cell (Moriyama et al., 1991).

A comparison of adult and foetal wound healing has shown that foetal wounds heal without scarring (Longaker and Adzick, 1991). This has been attributed to a lower inflammatory response (Whitby and Ferguson, 1991a) and a different cytokine profile (Whitby and Ferguson, 1991b), which suggests that manipulation of wound healing by altering the cytokine profile could lead to scarless healing. Only a few cytokines have been identified that have the potential to reduce scarring; interferons represent the first well-defined group of polypeptides that exert this property (Granstein et al., 1990a).

The ability of interferons to modulate wound healing has been studied in vivo and on a variety of cell types in vitro. IFN-α, IFN-β and IFN-γ reduce collagen synthesis by dermal fibroblasts (Duncan et al., 1995), hypertrophic scar fibroblasts (Tredget et al., 1993) and fibroblasts derived from sclerodermal lesions (Duncan and Berman, 1987). In vivo studies in mice have demonstrated that IFN-γ reduced the increased collagen synthesis associated with the fibrotic response to an implanted foreign body (Granstein et al., 1990a). This effect was also found in bleomycin-induced pulmonary fibrosis and the healing response to cutaneous burn wounds (Granstein et al., 1990a). The therapeutic relevance of these in vitro and in vivo observations has been confirmed in clinical trials. Intralesional injection of IFN-α2b (Berman and Duncan, 1989) or IFN-γ (Granstein et al., 1990b) reduced the sizes of keloid and hypertrophic scars (Larrabee et al., 1990).

The regulation of protein and collagen synthesis in normal fibroblasts by interferon in vitro depends on the anatomical site (Smith and Higgins, 1993, Martens et al., 1992). Moreover, dermal fibroblasts show a modulated response to IFN-γ according to their stage of differentiation during wound healing (Moulin et al., 1998). For wound healing factors such as migration (Irwin et al., 1994) and matrix remodelling (Stephens et al., 1996), it has been shown that there are phenotypic differences between dermal and oral fibroblasts. Therefore it is quite possible that there are differences in the regulation of proliferation and protein synthesis by interferons between dermal and oral fibroblasts, and between fibroblasts from palatal granulation tissue and normal palatal tissue.

Our aim now was to determine the effects of interferons on proliferation, collagen synthesis, and non-collagenous protein synthesis of mucoperiosteal granulation and normal fibroblasts.

Section snippets

Interferons

Human recombinant IFN-α2b was obtained from Schering Plough BV (Amstelveen, The Netherlands). Fibroblast-derived human IFN-β was obtained from ICN Pharmaceuticals (Costa Mesa, USA) and rat recombinant IFN-γ was kindly provided by Dr P.H. van der Meide, (BPRC Rijswijk, The Netherlands).

Fibroblast cultures

Five-week-old male Wistar rats were anaesthetized with a subcutaneous injection of 0.4 ml/kg body wt fentanyl+fluanisone (Hypnorm®; Janssen-Cilaq, Beerse, Belgium). A standardized wound was made in the

Collagen and non-collagenous protein synthesis of untreated fibroblasts

Palatal granulation fibroblasts produced significantly 42% more collagen than normal fibroblasts. Although not significant, granulation fibroblasts produced 24% more non-collagenous proteins than normal fibroblasts (Table 1).

Interferon-α2b

Although IFN-α2b tended to reduce the proliferation (Fig. 1A) of granulation and normal fibroblasts by about 10–20%, there were no significant effects. Also, the collagen (Fig. 1B) and non-collagenous protein synthesis (Fig. 1C) of granulation and normal fibroblasts were

Discussion

We have determined the effects of interferons on proliferation, collagen and non-collagenous protein synthesis of granulation-tissue fibroblasts. We have evidence that in this rat model the vast majority of fibroblasts in the granulation tissue are myofibroblasts at 8 days after wounding (A.M.H. Cornelissen et al., unpublished data). Myofibroblasts are involved in wound contraction, matrix synthesis, and remodelling. They have been associated with scar tissue formation (Estes et al., 1994),

Acknowledgements

We are grateful to Dr PH van der Meide (Biomedical Primate Research Centre, Rijswijk, The Netherlands) for the gift of IFN-γ.

References (30)

  • D.J. Whitby et al.

    Immunohistological localisation of growth factors in fetal wound healing

    Developmental Biology

    (1991)
  • D.M. Butler et al.

    Stimulation of human synovial fibroblasts DNA synthesis by recombinant human cytokines

    Journal of Rheumatology

    (1988)
  • J.E. Darnell et al.

    Jak-STAT Pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins

    Science

    (1994)
  • A. Desmoulière et al.

    The role of the myofibroblasts in wound healing and fibrocontractive diseases

  • M.R. Duncan et al.

    γ Interferon is the lymphokine and β interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation

    Journal of Experimental Medicine

    (1985)
  • Cited by (24)

    • The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-γ-induced murine fibroblast proliferation

      2002, Journal of Biological Chemistry
      Citation Excerpt :

      These observations that mGBP-2 and the GTP-binding mutant show intracellular distributions indistinguishable from the endogenous protein suggest that any differences in the phenotype observed for these cells are not the consequence of gross mistargeting of the respective proteins. Whereas interferons induce an antiproliferative response in many cells, one notable exception is fibroblasts, where IFN-γ treatment can promote primary fibroblast proliferation in vitro (40-46). Consequently, the NIH 3T3 cells expressing mGBP-2 and the GTP-binding mutant were examined for changes in their growth properties.

    • Antifibrotic therapy for the treatment of pulmonary fibrosis

      2001, American Journal of the Medical Sciences
      Citation Excerpt :

      Published reports indicate that interferon β can inhibit proliferation of, chemotaxis of, and collagen production by human fibroblasts in vitro. Interferon β was recently reported to reduce the synthesis of collagen, but not noncollagenous proteins, by palatal granulation fibroblasts.69 Furthermore, short-term interferon exposure to cultured scleroderma fibroblasts induced a reduced collagen producing phenotype that was maintained in the absence of interferons.

    View all citing articles on Scopus
    View full text